News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 253–288
- Matches
- 468
- Sources here
- 15
- Companies here
- 10
Active search
468 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Nexgel Inc (NXGL) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Nexgel Inc (NXGL), highlighting its beta value of 0.74, indicating lower volatility compared to the S&P 500. The company's current risk assessment score is 2.23, placing it 130th out of 155 in the Pharmaceuticals industry. The analysis …
Sol Gel Technologies Ltd (SLGL) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis for Sol Gel Technologies Ltd (SLGL), indicating its current valuation score is 9.47 and ranks 16th within the Biotechnology & Medical Research industry. It details the company's current P/E ratio, noting its deviation from recent highs and lows. …
North American sporting goods retailer adds tools for shopper insight
Bridgeline Digital (NASDAQ: BLIN) announced that a major North American sporting goods retailer has expanded its use of the HawkSearch platform, originally adopted in 2023. The retailer is adding Advanced Reports and additional infrastructure to enhance analytics, gain deeper shopper insights, and optimize product …
SLGL|Sol Gel Technologies Ltd|Price:82.730|Chg%:-2.460
This article provides a comprehensive stock analysis of Sol Gel Technologies Ltd (SLGL), highlighting its strong fundamentals, high growth potential, and current "fairly valued" status. Institutional ownership is noted as very high, and analysts have issued "Buy" ratings with a high price target. While …
NXGL|Nexgel Inc|Price:0.415|Chg%:-0.029
This article provides a comprehensive stock analysis of Nexgel Inc (NXGL) from TradingKey, highlighting its stable fundamentals, high growth potential, and fair valuation within the Pharmaceuticals industry. The company's stock score details its financial health, institutional confidence, and an analyst rating of "Buy" with …
Leading Sports Goods Retailer Expands Investment in Bridgeline's HawkSearch Platform
A leading North American sporting goods retailer has expanded its use of Bridgeline Digital's HawkSearch platform, integrating advanced analytics and search optimization capabilities. This expansion, building on a relationship since 2023, reflects the growing demand for AI-powered solutions to enhance product discovery, understand customer …
Angel Oak FINS (NYSE: FINS) hit with activist push to replace trustee and cut adviser
Angel Oak Financial Strategies Income Term Trust (FINS) is facing an activist proxy challenge from shareholder Trevor Montano. Montano, who owns 66,100 shares, is seeking to elect himself as a Class II Trustee and terminate the Fund's Investment Advisory Agreement with Angel Oak Capital …
Understanding the Setup: (GEL) and Scalable Risk
This article provides an analysis of Genesis Energy L.p. (NYSE: GEL), highlighting a neutral sentiment across all time horizons, indicating a wait-and-see approach. It details an exceptional 36.7:1 risk-reward setup targeting a 10.2% gain versus 0.3% risk, along with specific institutional trading strategies for …
Nexgel Inc (NXGL) Institutional Confidence
Nexgel Inc (NXGL) has an institutional confidence score of 3.00, placing it 92nd out of 155 in the Pharmaceuticals industry. Institutional shareholding has increased by 118.57% quarter-over-quarter, now standing at 14.76%. James Simons is the largest institutional shareholder, holding 0.60% of outstanding shares.
Genesis Energy (GEL) Projected to Post Earnings on Thursday
Genesis Energy (GEL) is expected to announce its Q2 2026 earnings before market open on Thursday, August 6th, with analysts projecting earnings of $0.02 per share and $444.7 million in revenue. This follows a previous quarter where the company missed estimates with a $0.06-per-share …
Rigel Pharmaceuticals Inc (RIGL) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Rigel Pharmaceuticals Inc (RIGL), noting its current risk score of 4.47 and ranking it 86th out of 155 in the Pharmaceuticals industry. It highlights the company's beta of 1.19, indicating higher volatility compared to the S&P 500 …
Aspen Aerogels Inc (ASPN) Financial Health: Profitability & Balance Sheet Analysis
This article analyzes the financial health of Aspen Aerogels Inc (ASPN), noting its robust financial status and high operating efficiency with a current financial score of 7.46, ranking 27 out of 65 in the Chemicals industry. Despite these strengths, the company experienced a significant …
Form 4 Nexgel Inc For: 29 July By Investing.com
This article reports on a Form 4 filing for Nexgel Inc. related to activity on July 29th. It is a brief financial news item from Investing.com, typical of filings news. The article provides the company name and filing date, without further details in the …
Sol-Gel Technologies Market Sentiment
This article provides an overview of market sentiment for Sol-Gel Technologies (SLGL), including analyst consensus, short interest, options flow, and insider activity. Analysts rate SLGL as "Outperform" with an average price target of $133, while short interest is declining, considered a bullish signal. Insider …
Earnings Preview: RIGL to Report Financial Results Post-market on August 04
This article announces that Rigel Pharmaceuticals (RIGL) is scheduled to release its financial results after market close on August 4. The company will also host a webcast and conference call at 4:30 PM ET to discuss these results, which will be accessible for replay.
Nexgel Inc (NXGL) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Nexgel Inc (NXGL), noting its current valuation score of 7.43, which ranks 123 out of 155 in the Pharmaceuticals industry. It highlights that the company's current P/E ratio is -1.10, indicating a decrease of 7.40% from its …
Adam Levy signs new employment agreement as NexGel CEO with revised pay and equity
NexGel (NXGL) has executed a new Executive Employment Agreement with its President and CEO, Adam Levy, effective July 23, 2026. This agreement outlines his salary, bonus potential, equity grants, and severance terms. The compensation package includes a base salary of $375,000 and options for …
Sol Gel Technologies Ltd (SLGL) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Sol Gel Technologies Ltd (SLGL), detailing its volatility, financial, and investment risks. The company's beta value is 1.15, indicating higher volatility compared to the S&P 500. Key metrics like maximum drawdown, Sharpe ratio, and daily returns over …
Bridgeline Digital Market Sentiment
This article provides an overview of Bridgeline Digital (BLIN) market sentiment, detailing analyst consensus, short interest, options flow, and insider activity. Key signals show a "Buy" analyst consensus with a price target of $5, very low short interest at 0.4%, and no recent options …
Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, after market close. Following the announcement, senior management will host a live conference call and webcast at 4:30 p.m. Eastern Time to discuss the …
Rigel Pharmaceuticals Inc (RIGL) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Rigel Pharmaceuticals Inc (RIGL), highlighting its current valuation score and P/E ratio. It notes that the company's P/E ratio is 1.90, significantly below its recent high and above its recent low. The analysis also indicates that relevant …
(FINS) Risk Channels and Responsive Allocation
This article provides an AI-generated analysis for Angel Oak Financial Strategies Income Term Trust (NASDAQ: FINS), indicating a neutral sentiment with a mid-channel oscillation pattern. It highlights a favorable 7.8:1 risk-reward setup, targeting a 2.5% gain against a 0.3% risk. The analysis also outlines …